Impact of immigration on tuberculosis in a low-incidence area of Italy: a molecular epidemiological approach  by Garzelli, C. et al.
Impact of immigration on tuberculosis in a low-incidence area of Italy:
a molecular epidemiological approach
C. Garzelli1, N. Lari1, B. Cuccu1, E. Tortoli2 and L. Rindi1
1) Dipartimento di Patologia Sperimentale, Biotecnologie Mediche, Infettivologia ed Epidemiologia, Universita` di Pisa, Pisa and 2) Centro Regionale di
Riferimento per i Micobatteri, Laboratorio di Microbiologia e Virologia, Ospedale Careggi, Firenze, Italy
Abstract
The effects that immigration might have on the epidemiology of tuberculosis (TB) in a low-incidence area of Italy was investigated by
determining, in autochthonous and immigrant TB patients, the molecular characteristics of the Mycobacterium tuberculosis complex
(MTBC) isolates, which may provide information on their phylogeographical origin. A total of 1080 MTBC strains, collected during a 4-
year period in Tuscany from 614 Italian-born and 466 foreign-born patients, were genotyped by spoligotyping and assigned to the differ-
ent phylogeographical lineages that constitute the MTBC. The autochthonous Euro-American phylogeographical lineage, which includes
the spoligotype families T, Haarlem, Latin American–Mediterranean (LAM), S and X, was highly prevalent among Italian-born patients,
with a total of 477 cases (77.7%), and foreign-born TB patients, with a total of 270 cases (57.9%); 24 Italian-born (3.9%) and 141 for-
eign-born (30.3%) TB cases were due to MTBC genotypic families associated with distant geographical areas, i.e. East African–Indian
(EAI), Beijing, Central Asian (CAS), and Mycobacterium africanum. Strains of Mycobacterium bovis and strains of undeﬁned genotype, which
are all considered together, as it is not possible to assign a speciﬁc geographical origin, accounted for 113 (18.4%) Italian cases and 55
(11.8%) foreign-born cases. A total of 79 Italian TB cases (12.9%) have been attributed to transmission from immigrants to the local
population. No signiﬁcant contribution to drug resistance appeared to be associated with imported MTBC strains. It is concluded that,
at present, the overall impact of imported TB on public health in the low-incidence study area is relatively modest and of the same
order as in other western countries.
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Introduction
Tuberculosis (TB) is the world’s second most common cause
of death from an infectious disease, after human immunodeﬁ-
ciency virus/AIDS, causing 50–100 million infections, 8–9 mil-
lion new cases and nearly 2 million deaths every year [1]. As
the global burden of TB falls principally on developing coun-
tries, accurate estimates of the role of immigration on the
epidemiology of TB in low-prevalence countries are essential
for the design of appropriate strategies for disease control.
In the present study, we investigated the impact that
immigration might have on TB in a low-incidence area of
Italy by determining the molecular characteristics of Mycobac-
terium tuberculosis complex (MTBC) isolates, which may pro-
vide information on their origin. The MTBC consists, in fact,
of different phylogeographical lineages [2–4], which are cur-
rently deﬁned by at least two major types of genomic poly-
morphism, i.e. polymorphisms of the DR locus, assessed with
the spoligotyping assay [5], and polymorphisms due to dele-
tions of large chromosomal regions, termed large-sequence
polymorphisms (LSPs) [3]. Spoligotyping classiﬁes the MTBC
strains into at least 15 families, including some heteroge-
neous ‘ill-deﬁned’ families [6]; LSP analysis, on the other
hand, classiﬁes MTBC strains into six major phylogeographi-
cal lineages [3,7]. In both cases, certain spoligotype families
or LSP-deﬁned lineages are associated with speciﬁc human
populations and geographical areas, whereas others are prac-
tically ubiquitous or, at least, widespread. If the two classiﬁ-
cation systems are combined, the MTBC lineages consist of:
(i) the Indo-Oceanic lineage, corresponding to the spoligo-
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type-deﬁned East African Indian (EAI) family, occurring all
around the Indian Ocean; (ii) the East Asian lineage, which
includes the spoligotype-deﬁned Beijing family, and is highly
prevalent in many countries of East and Southeast Asia and
is rapidly spreading in eastern Europe; (iii) the East African–
Indian lineage, which is prevalent in East Africa, North India
and Pakistan, and includes the spoligotype-deﬁned Central
Asian (CAS) family; (iv) the evolutionarily more recent Euro-
American lineage, which is the most frequent lineage in Eur-
ope and the Americas, and has also spread across different
regions of Africa and the Middle East, and includes the spoli-
gotype families T, Haarlem, Latin American–Mediterranean
(LAM), S and X; and (v) the West African I and the West
African II lineages (from which Mycobacterium bovis origi-
nated), corresponding to strains traditionally identiﬁed as
Mycobacterium africanum [3].
In this investigation, MTBC strains isolated from Italian-
born and foreign-born patients during a 4-year period in Tus-
cany, a region of central Italy with a low incidence of TB,
were genotyped by spoligotyping and assigned to the differ-
ent phylogeographical lineages, in order to quantitate autoch-
thonous and imported MTBC strains, to monitor incoming
and expanding genotypes, to estimate the extent of transmis-
sion of imported strains to the local population and, ﬁnally,
to evaluate the contribution, if any, of immigration to drug
resistance in circulating MTBC strains.
Materials and Methods
Clinical isolates
A total of 1080 MTBC isolates were collected during a 4-
year period, from 1 January 2002 to 31 December 2005,
from the same number of TB patients hospitalized in Tus-
cany, Italy. The study isolates represent the vast majority
(>90%) of the solates in the region during the study period.
All isolates were identiﬁed using DNA molecular probes
(Accuprobe (Gen-Probe, San Diego, USA) and/or InnoLipa
(Innogenetics, Ghent, Belgium)). The drug susceptibilities of
isolates were determined with the radiometric BAC-
TEC 460 TB system or the ﬂuorimetric MGIT 960 system
(Becton Dickinson, Towson, MD, USA), in accordance with
the manufacturers’ recommendations.
Spoligotyping and phylogeographical lineages
Spoligotyping analysis of the isolates was performed basically
as described by Kamerbeek et al. [5]. MTBC isolates were
assigned to one of the 15 genotypic families deﬁned in the
international spoligotype database SpolDB4 of the Pasteur
Institute of Guadeloupe [6], according to speciﬁc rules deﬁn-
ing the major phylogenetic families for M. tuberculosis sen-
su stricto, i.e. EAI, Beijing, CAS, T, Haarlem, LAM, S and X,
as well as signatures for the species M. africanum and
M. bovis. In a second step, the spoligotype families were
assigned to the LSP-based phylogeographical lineages
deﬁned by Gagneaux et al. [3,4]: in particular, isolates of the
T, Haarlem, LAM, S and X families were assigned to the
Euro-American lineage; the EAI, Beijing and CAS families
were assigned to the Indo-Oceanic, East Asian and East
African–Indian lineages, respectively; isolates with spoligotype
signatures for M. africanum and M. bovis were considered to
be distinct genotypic lineages.
Results and Discussion
Study patients
Tuscany is a region of central Italy, a low-incidence country
with notiﬁcation rates of bacteriologically conﬁrmed TB cases
ranging from six to ten per 100 000 population in the last
25 years. During the study years, the population of Tuscany
was 3.5–3.6 · 106 persons, of whom approximately 5–6%
were foreign-born. The epidemiological features of study TB
patients are summarized in Table 1. The country of birth of
the 1080 study patients was known for 94.5% patients; 614
(56.9%) were Italian-born, and 466 (43.1%) were foreign-
born. The Italian-born/foreign-born ratio decreased from 1.62
in 2002 to 1.15 in 2005, indicating a steady increase in for-
eign-born TB cases. Of the foreign-born patients, 27.9% were
from Africa, 23.6% from Asia, 22.3% from Eastern Europe,
and 11.6% from Central and South America.
Distribution of MTBC clinical isolates among phylogeo-
graphical lineages
The MTBC clinical isolates were genotyped by spoligo-
typing and assigned to the spoligotype families and LSP
TABLE 1. The tuberculosis (TB) patients in this study
TB patients
Year
Total2002 2003 2004 2005
No. of TB patients
Total 254 268 306 252 1080
No. of Italian-born patients 157 152 170 135 614
No. of foreign-born patients 97 116 136 117 466
Italian-born/foreign-born ratio 1.62 1.31 1.25 1.15 1.32
No. of foreign-born patients from:
Africa 36 35 30 29 130
Asia 19 25 33 33 110
Eastern Europe 11 24 40 29 104
Central and South America 11 13 14 16 54
Other countriesa 20 19 19 10 68
aIncludes patients from western Europe, North America, and Oceania, and
patients whose country of birth is unknown.
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phylogeographical lineages according to the criteria
reported in Materials and Methods. The distribution of
MTBC isolates from Italian-born and foreign-born patients
among the genotypic lineages and the geographical origins
of foreign-born patients are given in Table 2; the time
courses for the different genotypic lineages for Italian-born
and foreign-born patients are reported in Fig. 1. The partic-
ular lineages were as follows.
TABLE 2. Distribution of Mycobacterium tuberculosis complex (MTBC) clinical isolates among genotypic lineages
MTBC genotypic lineagea and
spoligotype-based familiesb
TB patients Geographical area of birth of foreign-born patients
Italian-
born
Foreign-
born Total (%) Africa Asia
Eastern
Europe
Central and
South America
Other
countriesc
Euro-American 477 270 747 (69.2) 90 17 80 35 48
T 213 98 29 9 39 7 14
Haarlem 137 93 21 4 32 17 19
LAM 69 69 37 3 5 10 14
S 50 4 2 – 2 – –
X 8 6 1 1 2 1 1
Indo-Oceanic, EAI 8 37 45 (4.2) 2 26 1 1 7
East Asian, Beijing 16 59 75 (6.9) 2 36 7 9 5
East African–Indian, CAS 0 29 29 (2.7) 5 21 – – 3
Mycobacterium africanum, AFRI 2 and 1 0 16 16 (1.5) 16 – – – –
Mycobacterium bovis, BOVIS 15 6 21 (1.9) 3 2 – 1 –
Undeﬁnedd 98 49 147 (13.6) 12 8 16 8 5
aAccording to Gagneux et al. [3], with modiﬁcations (see text).
bBased on spoligotyping according to Brudey et al. [6].
cIncludes western Europe, North America, and Oceania, and patients whose country of birth is unknown.
dIncludes isolates with a signature that is as yet undeﬁned or with uncertain classiﬁcation in SpolDB4.
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FIG. 1. Distribution of Mycobacterium tuberculosis complex clinical isolates among genotypic lineages in Italian-born and foreign-born tuberculosis
patients during the years 2002–2005 in Tuscany, Italy. The spoligotype-deﬁned family of isolates is given above each panel. CAS, Central Asian;
EAI, East African–Indian; LAM, Latin American–Mediterranean.
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Euro-American lineage. As expected, MTBC isolates of the
widespread Euro-American lineage were highly prevalent
and represented 69.2% of all isolates. Within this lineage,
the spoligotype families were ranked in the following order:
T (41.6% of all Euro-American isolates), Haarlem (30.8%),
LAM (18.5%), S (7.2%) and X (1.9%). The distribution of
isolates of the ubiquitous T family in general reﬂected the
proportions of Italian-born and foreign-born patients
(Fig. 1). For foreign-born patients, eastern Europe and
Africa accounted for the large majority of cases. Isolates of
the Haarlem family were also proportionally distributed
between Italian-born and foreign-born patients; however,
Haarlem isolates from Italian-born patients showed a
decrease in frequency, whereas they increased in frequency
among foreign-born patients (Fig. 1); eastern Europe, Africa
and the Americas were the major geographical areas of
birth of Haarlem TB patients. The LAM isolates were, on
the whole, equally distributed between Italian-born and for-
eign-born patients, with a small, if any, decrease in fre-
quency among Italian-born patients and a moderate increase
in frequency in foreign-born patients; as expected, Africa
(particularly the Mediterranean countries) and South Amer-
ica accounted for the origins of most patients. The autoch-
thonous S family was highly prevalent among Italian-born
patients (50 of 54 patients, 92.6%); these strains showed a
decrease in frequency over the years. Interestingly, no TB
case due to S strains was found among immigrants in the
ﬁrst 3 years of the survey; all foreign-born cases (two from
North Africa and two from eastern Europe) occurred in
2005. X strains, of Anglo-Saxon origin, were rarely found
(1.3% of the total).
Indo-Oceanic lineage. A total of 45 isolates (4.2%) were of the
Indo-Oceanic phylogeographical lineage (EAI family, according
to spoligotyping), which is prevalent all around the Indian
Ocean. Most isolates were from Asian patients; only three
Italian patients were infected by this genotype in the years
2002–2004, but ﬁve Italian TB cases with EAI isolates were
recorded in 2005, all of them sharing the rare SIT2852 spoli-
gotype; these isolates clustered with a sixth SIT2852 isolate
from a patient from the Philippines, thus suggesting the pos-
sibility of a recent TB outbreak.
East Asian lineage. A relatively high number of isolates (75,
6.9% of the total) belonged to the East Asian phylogeographi-
cal lineage, in particular to the Beijing family which included
68 ‘true’ Beijing strains (SIT1) and seven Beijing-like strains.
Most patients with Beijing strains (78.7%) were foreign-born;
Asia, and China in particular, accounted for the origin of
most patients (36 of 59); this was expected, as Asia has been
the main source of importation of Beijing strains to Euro-
pean countries [8,9]; there was also a consistent proportion
from eastern Europe and South America (Peru in particular);
this ﬁnding seems not to be casual, as the South American
route of importation of Beijing strains to Europe has already
been reported from Spain [10].
Importantly, the proportion of foreign-born Beijing
patients increased during the years of our survey (Fig. 1).
Also, the number of Italian-born Beijing patients was rela-
tively high (16 patients, 21.3%), consisting of three to ﬁve
patients each year, which might indicate ongoing active trans-
mission of Beijing TB involving autochthonous residents.
East African–Indian lineage. Strains of the East African–Indian
phylogeographical lineage (CAS family, according to spoligo-
typing) were exclusively found in foreign-born patients,
mostly (21 of 29, 72.4%) from Asia (Pakistan in particular).
Starting from 2003, the frequency of this genotype seems to
be increasing in the region (Fig. 1).
M. africanum. M. africanum strains were similarly isolated only
from foreign-born patients, all from Africa, but their number
showed a steady decrease (Fig. 1).
M. bovis. M. bovis strains (21 isolates) accounted for just
under 2% of all TB cases. Most M. bovis TB cases (15 cases,
three of which were caused by M. bovis bacille Calmette–
Gue´rin) occurred in Italian-born patients aged 33–93 years
(mean, 69 years), which probably indicates, at least in most
cases, a reactivation of a remote infection; the six foreign-
born patients with M. bovis TB were young people (mean
age, 28 years; range, 21–38 years), indicating a recently
acquired infection.
Considerations concerning the impact of immigration on
the spread of TB
From the data in Table 2, it appears that only 24 Italian TB
cases of 614 (3.9%) were due to MTBC strains of genotypic
families (EAI and Beijing) typical of distant geographical areas.
These strains, which were very probably transmitted from
immigrants to the local population, constitute approximately
17% of the 141 strains, isolated from immigrants, that are
prevalent in distant geographical areas, i.e. strains of the
Indo-Oceanic (EAI), East-Asian (Beijing), East African–Indian
(CAS) and M. africanum genotypes. Assuming that strains of
the Euro-American lineage (270 in foreign-born patients) and
strains of M. bovis or undeﬁned genotypes (55 altogether)
were also transmitted from immigrants to the local popula-
tion to the same extent (i.e. 17%), it can be calculated that
in Italian-born patients a further 46 and nine cases could be,
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at least theoretically, attributed to imported Euro-American
and M. bovis/undeﬁned strains, respectively. This gives a total
of 79 cases of 614 (12.9%) TB cases that were potentially
transmitted from immigrants to the local population. Obvi-
ously, this proportion is theoretical, and its estimation is per-
haps too simplistic. It probably overestimates the proportion
of imported strains transmitted to the local population
because of at least two factors: (i) not all of the TB cases in
foreign-born patients may be due to infections acquired in
their native countries, as indicated by the TB cases in immi-
grants caused by the strains of the local S genotype—in this
regard, extensive transmission between the local and for-
eign-born populations, caused mainly by autochthonous
strains, has been reported from Madrid, Spain [11]; and (ii)
our estimate is based on the assumption that all MTBC
strains are transmitted with the same efﬁciency, and does
not take into consideration that the MTBC genotypic families
may be endowed with different transmissibility proper-
ties—for example, direct human-to-human transmission
seems to be rare for M. bovis, but, on the other hand, highly
efﬁcient for the M. tuberculosis Beijing family [12,13].
Thus, at present, it appears that in our low-incidence area
the overall impact of imported TB on public health is rela-
tively modest and of the same order as in other western
areas. In fact, the estimated proportion of native-born TB
cases that can be attributed to transmission from the for-
eign-born individuals has been reported to be of the order
11–17% in Dutch, Canadian and US cities [14–18]. Several
other reports from western countries generally agree that
immigration has little impact on transmission of TB to local
populations, although it may help to maintain or increase the
total number of cases of disease [19–23]. Hirsh et al. [7]
have proposed a stable association between the TB pathogen
and host that restricts the spread of the organism among dif-
ferent populations. This view, however, is only partly con-
ﬁrmed in our setting, as, considering the phylogeographical
lineages other than the Euro-American lineage, only the East
African–Indian (CAS) and the M. africanum strains remained
associated with their host populations, without any transmis-
sion to the local population, whereas several cases of TB
caused by Indo-Oceanic (EAI) and East Asian (Beijing) strains
did occur among Italian born-patients. In this regard, the
Beijing family of strains raises concern, as their prevalence
(6.9%), although markedly lower than that reported in East
and Southeast Asia and in eastern Europe, is higher than that
reported in other western European countries [12]; more-
over, Beijing strains are rapidly spreading worldwide
[12,24,25], are, in general, considered to be hypervirulent
[26,27], and have a propensity to develop drug resistance
[12].
Drug resistance of MTBC isolates
As shown in Table 3, of a total of 1051 MTBC clinical iso-
lates from Italian-born and foreign-born patients for which
drug resistance data were available, 86.0% were susceptible
to all ﬁrst-line anti-TB drugs tested, i.e. rifampin, isoniazid,
TABLE 3. Drug resistance of Mycobacterium tuberculosis complex (MTBC) clinical isolates in Italian-born and foreign-born
tuberculosis (TB) patients
TB patients
Pan-
susceptible,
no. (%)
Any drug resistancea MDR
MTBC genotypic lineage MTBC genotypic lineage
All
lineages,
no. (%)
Euro-
American,
no.
Other than
Euro-American,
no.
Undeﬁned
and
BOVIS, no.
All
lineages,
no. (%)
Euro-
American,
no.
Other than
Euro-American,
no.
Undeﬁned
and
BOVIS, no.
Italian-born,
n = 597
521 (87.3) 68 (11.4) Total 44
17 T
13 Haarlem
8 LAM
6 S
Total 3
3 Beijing
Total 21
14 undeﬁned
7 BOVIS
8 (1.3) Total 7
3 T
2 Haarlem
1 LAM
1 S
– Total 1
1 undeﬁned
Foreign-born,
n = 454
383 (84.4) 58 (12.8) Total 35
14 T
9 Haarlem
10 LAM
1 S
1 X
Total 15
7 Beijing
4 CAS
2 EAI
2 AFRI
Total 8
6 undeﬁned
2 BOVIS
13 (2.9) Total 9
4 T
4 Haarlem
1 LAM
Total 4
3 Beijing
1 EAI
–
Total, n = 1051 904 (86.0) 126 (12.0) Total 79
31 T
22 Haarlem
18 LAM
7 S
1 X
Total 18
10 Beijing
4 CAS
2 EAI
2 AFRI
Total 29
20 undeﬁned
9 BOVIS
21 (2.0) Total 16
7 T
6 Haarlem
2 LAM
1 S
Total 4
3 Beijing
1 EAI
Total 1
1 undeﬁned
CAS, Central Asian; EAI, East African–Indian; LAM, Latin American–Mediterranean; MDR, multidrug-resistant, i.e. resistant to at least rifampin and isoniazid.
aIncludes isolates, other than MDR isolates, that are resistant to one or more ﬁrst-line anti-TB drugs (rifampin, isoniazid, pyrazinamide, ethambutol and streptomycin).
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pyrazinamide and ethambutol (data for streptomycin suscep-
tibility were available for 346 isolates); 12.0% were resistant
to one or more ﬁrst-line drugs; and 2.0% were multidrug-
resistant (MDR), i.e. resistant to at least rifampin and isonia-
zid. No extensively drug-resistant isolate was found. The
proportions of isolates resistant to any drug did not differ
statistically between Italian-born (11.4%) and foreign-born
(12.8%) patients. The proportion of MDR isolates from for-
eign-born patients (13 of 454, 2.9%) was more than twice as
high as that from Italian-born patients (8 of 597, 1.3%), but
the difference did not reach statistical signiﬁcance.
With regard to the phylogeographical lineages, most iso-
lates resistant to one or more anti-TB drugs belonged to the
Euro-American lineage (44 of 68 from Italian-born and 35 of
58 from foreign-born patients), with no particular prevalence
of a particular spoligotype family being seen. Among the
other phylogenetic lineages, drug resistance was restricted to
three Beijing isolates from Italian-born patients and 15 iso-
lates from foreign-born patients; in these patients, Beijing iso-
lates accounted for approximately half (seven of 15) of the
drug-resistant isolates. Most MDR isolates belonged to fami-
lies of the Euro-American lineage, particularly T and Haar-
lem, in both Italian-born and foreign-born patients; no MDR
isolate of genotypic lineage other than Euro-American was
found among Italian patients, whereas one EAI isolate and
three Beijing MDR isolates were detected among foreign-
born patients.
In conclusion, in Tuscany, Italy, despite the high and
increasing proportion of TB cases in immigrants, transmis-
sion of imported MTBC strains to the local population
appears to be relatively modest at present; moreover,
immigration does not seem to have a signiﬁcant impact on
the drug resistance of circulating strains. It should be
underscored, however, that the impact of the imported TB
on the spread of the disease to the local population is difﬁ-
cult to measure or forecast, owing to the chronic nature
of TB, as infected individuals may stay latently infected for
many years before they develop active TB. This highlights
the need for continued and improved surveillance for TB
among the local-born population and newly arrived
immigrants, especially those from countries with high
endemicity.
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